TABLE 1.
Anticancer effect of AA through different pathways.
| Pathway | Effect of AA | Upregulated genes | Downregulated genes | Cell/Model organism | Reference |
|---|---|---|---|---|---|
| Cell Cycle Arrest | AA caused G2/M cell arrest and subG0 -G1 phase cell cycle arrest in MCF-7 cells. It also arrested NSCLC, PC-9 and H1975 cells at the G0/G1 phase | - | Cyclin D1, cdk4 | MCF-7, NSCLC, PC-9, H1975 | Haffez et al. (2022) |
| Liu et al. (2019) | |||||
| Mitochondrial Pathway | AA downregulated the Bcl-2 and upregulated the Bax, released Cyt-c from mitochondria, increased the expression of cleaved parp, and resulted in apoptosis in MCF-7 and NSCLC cells | Bax, Cleaved parp | Bcl-2 | MCF-7, NSCLC | Haffez et al. (2022) |
| Liu et al. (2019) | |||||
| Extrinsic Apoptotic Pathway (EAP) | AA regulated the EAP through overexpression of apoptotic genes Fas, Fasl which further increased the expression of caspase-8, leading to activation of caspase-3 and apoptosis | Fas, Fasl, Caspase-8, Caspase-3 | - | MCF-7 | Haffez et al. (2022) |
| AMPK Pathway | AA downregulated PKC-a levels while overexpressing PRKAA1, a key kinase in MCF-7 resistance and metastasis cells. This overexpression activated AMPK. | PRKAA1 | PKC-a | MCF-7 | Haffez et al. (2022) |
| PI3K/Akt, ERK Pathways | AA caused a gradual decrease in PI3K protein levels and significantly inhibited Akt activation in a dose-dependent manner. There was no significant influence on phosphorylated p38 or phosphorylated ERK1/2 | - | PI3K, Akt | Not specified | Hsieh et al. (2015) |
| Nuclear Factor Kappa B (NF-kB) Pathway | In NSCLC, AA downregulated the TNF-α induced activation of IKKβ, IkB and blocked the NF-kB nuclear translocation dose-dependently. AA directly bound to IKKβ, while its binding with IKKα was much lower, suggesting specificity for IKKβ. In addition, AA downregulated the proliferation (VEGF, IGFR1, TGF-β) and oncogenic genes (C-myc and NF-κB), and increased levels of antioxidants | - | IKKβ, IkB, VEGF, IGFR1, TGF-β, C-myc, NF-κB | NSCLC | Liu et al. (2019) |
| Haffez et al. (2022) | |||||
| Ferroptosis in Cancer | AA has a selective effect on inhibiting the viability of bladder cancer (BC) cell lines (J82, T-24, 5637) in a time and dose dependent manner. It has little effect on the normal urothelial cell line SV-HUC-1. AA induces ferroptosis in BC cells through upregulation of GPX4 which further affects the MDA, iron and GSH level in BC cells. AA treatment reduced lung metastasis of B16F10 cells in mice, resulting in lower mean lung weight and fewer countable nodules in the lungs compared to the control group. AA effectively reduced tumor size in mice with breast cancer xenografts, without affecting the mice’s body weight | GPX4, HMOX1, Nrf2, DDT3, ATF4, SOD1, HSPB1, P53, XBP1, catalase, GRX1, HO-1 | - | BC (J82, T-24, 5637), SV-HUC-1, B16F10 (mice), Breast cancer xenografts (mice) | Xu et al. (2023) |